EMST in Patients Undergoing CRT for HNCA
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Wisconsin, Milwaukee
About this trial
This study is a randomized trial examining the impact of expiratory muscle strength training (EMST) on maintenance of safe and efficient oropharyngeal swallow function in persons with cancer of the head and neck (HNCA) undergoing treatment with radiation therapy or chemoradiotherapy (RT/CRT).
Eligibility criteria
Qualifiers
New diagnosis of cancer in the oral cavity, oropharynx, hypopharynx, or larynx;
Planned treatment with primary radiotherapy with or without chemotherapy;
Age 18 or older and able to provide consent;
Ability to use the EMST150 device (hold in mouth and maintain lip seal)
Disqualifiers
Primary surgery to the head and neck (neck dissection is permitted);
Unknown primary tumor;
Primary cancers of the nasopharynx, paranasal sinuses, salivary glands and skin.
Progressive neurologic condition affecting muscle strength (e.g. amyotrophic lateral sclerosis (ALS), Parkinson's disease)
Trial design
Treatments tested in this trial
- EMST
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Wisconsin, Milwaukee
Lead sponsor
Froedtert Hospital
Collaborator
Medical College of Wisconsin
Collaborator
Source ClinicalTrials.gov